by Madaline Spencer | Sep 17, 2024
Bruce Leuchter, MD, co-founder and CEO of Neurvati Neurosciences and GRIN Therapeutics, discusses topline results from clinical trial testing investigational radiprodil for GRIN-related disorders. GRIN-related neurodevelopmental disorders are a family of...
by Madaline Spencer | Sep 12, 2024
Richard Bedlack, MD, PhD, Stewart, Hughes and Wendt Distinguished Professor of ALS at Duke University, discusses a study identifying genetic associations with amyotrophic lateral sclerosis (ALS) reversals. ALS, also referred to as “Lou...
by Madaline Spencer | Sep 11, 2024
Ben Zimmer, CEO of Priovant Therapeutics, discusses the VALOR clinical trial testing investigational therapy for dermatomyositis treatment, brepocitinib. Dermatomyositis is a rare autoimmune condition that causes skin changes and muscle weakness....
by Madaline Spencer | Sep 6, 2024
Corey Cutler, MD, Director of Adult Stem Cell Transplantation Program at Dana-Farber Cancer Institute in Boston and a Professor of Medicine at Harvard Medical School, discusses the approval of Niktimvo (axatilimab) for the treatment of chronic graft versus host...
by Madaline Spencer | Sep 5, 2024
Ryan Motte, PharmD, Clinical Pharmacist at Shields Health Solutions, discusses recent data concerning the global cancer burden among men and projections for the year 2050. Men are disproportionately affected by modifiable risk factors such as smoking and...
